“…Given the close relationship between physiological and/or pharmacological external cues and the impact on the systemic metabolic profile, this experimental approach has been extensively used in nutrition, 72,73 agricultural, 74,75 dairy, 76,77 toxicology, 78,79 preclinical, and clinical studies. In life sciences, targeted metabolomics has been mainly employed for the characterization of known metabolites and pathways (i.e., amino acids, glycolysis, Krebs cycle, and pentose phosphate pathway) in in vitro, ex vivo, and in vivo experimental settings 6,80–90 . On the other hand, untargeted metabolomics is mainly used for the identification of biomarkers in biomedical research, for instance, in pathophysiology (i.e., cancer, 91 neurodegenerative diseases, 92,93 and metabolic disorders 94 ) or epidemiology studies 95,96 .…”